Methods for ligand discovery

Details Methods for ligand discovery Methods for ligand discovery

2006-02-14

2006-02-14

Wang, Andrew (Department: 1639)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S007100

Reexamination Certificate

active

06998233

ABSTRACT:
The present invention provides novel methods for ligand discovery. The inventive methods rely on a process termed “tethering” where potential ligands are covalently bonded or “tethered” to a target and subsequently identified.

REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5367058 (1994-11-01), Pitner et al.
patent: 5422281 (1995-06-01), Harris et al.
patent: 5571681 (1996-11-01), Janda
patent: 5783384 (1998-07-01), Verdine
patent: 5958702 (1999-09-01), Benner
patent: 0 801 307 (1997-10-01), None
patent: WO 95/18972 (1995-07-01), None
patent: WO 95/25737 (1995-09-01), None
patent: WO 96/13613 (1996-05-01), None
patent: WO 96/27605 (1996-09-01), None
patent: WO 97/12897 (1997-04-01), None
patent: WO 97/35202 (1997-11-01), None
patent: WO 97/43302 (1997-11-01), None
patent: WO 98/11436 (1998-03-01), None
patent: WO 98/11437 (1998-03-01), None
patent: WO 98/15969 (1998-04-01), None
patent: WO 98/25146 (1998-06-01), None
patent: WO 98/56028 (1998-10-01), None
patent: WO 98/56028 (1998-12-01), None
patent: WO 99/49314 (1999-09-01), None
patent: WO 99/50668 (1999-10-01), None
patent: WO 99/50669 (1999-10-01), None
patent: WO 99/63944 (1999-12-01), None
patent: WO 00/00823 (2000-01-01), None
patent: WO 00/03240 (2000-01-01), None
patent: WO 01/02856 (2001-01-01), None
patent: WO 02/42773 (2002-05-01), None
Siuzdak, G. Mass Spectrometry for Biotechnology. New York: Academic Press. 1996, pp. 119-126.
Marchand-Brynaert, J. et al., “Design and Synthesis of a Bifunctional Label for Selection of β-Lactamase displayed on Filamentous Bacteriophage by Catalytic Activity”Tetrahedron52(15):5591-5606 (1996).
Abraham, D.J. et al., How Allosteric Effectors Can Bind to the Same Protein Residue and Produce Opposite Shifts in the Allosteric EquilibriumBiochemistry34:150006-15020 (1995).
Boyiri, T. et al., “Bisaldehyde Allosteric Effectors as Molecular Ratchets and Probes”Biochemistry34:15021-15036 (1995).
Bunyapaiboonsri et al., “Dynamic Deconvolution of a Pre- Equilibrated Dynamic Combinatorial Library of Acetylcholinesterase Inhibitors”ChemBioChem2:438:444 (2001).
DeJarias et al., “Use of X-ray Co-crystal Structures and Molecular Modeling to Design Potent and Selective Non-peptide Inhibitors of Cathepsin K”J. Am. Chem. Soc.120(35):9114-9115 (1998).
Erlanson et al., “Site-Directed ligand discovery”PNAS97(17):9367-9372 (Aug. 15, 2000).
Hopkins et al., “Suicide Inhibitor of Cytochrome P450 1A1 and P450 2B1”Biochem. Pharmacol.44(4):787-796 (1992).
Huc and Lehn, “Virtual combinatorial libraries: Dynamic generation of molecular and supramolecular diversity by self-assembly”Proc. Natl. Acad. Sci. USA94:2106-2110 (Mar. 1997).
Jones and Thornton, “Principles of protein—protein interactions”Proc. Natl. Acad. Sci. USA93:13-20 (Jan. 1996).
Lehn, Jean-Marie, “Dynamic Combinatorial Chemistry and Virtual Combinatorial Libraries”Chem. Eur. J.5(9)2455-2463 (1999).
Maly et al., “Combinatorial target-guided ligand assembly: identification of potent sybtype-selective c-Src inhibitors”PNAS97(6):2419-2424 (Mar. 14, 2000).
Misumi et al., “The p2gagPeptide, AEAMSQVTNTATIM, Processed for HIC 1 Pr55gagwas found to be a Suicide Inhibitor of HIV-1 Protease”Biochem. Biophys. Res. Commun.241(2):275-280 (1997).
Thompson et al., “Design of potent and selective human cathepsin K inhibitors that span the active site”,Proc. Natl. Acad. Sci USA94, 14249-14254 (1997).
Feroozesh et al., “Aryl Acetylenes as Mechanism Based Inhibitors of Cytochrome P450-Dependent Mongoxugenase Enzymes”Chem. Res. Toxicol.10(1):91-102 (1997).
Nicolaou et al., “Combinatorial Synthesis Through Disulfide Exchange: Discovery of Potent Psammaplin A Type Antibacterial Agents Active against Methicillin-Resistant Staphylociccus Aureus (MRSA)”Chem. Eur. J.7(19):4280-4295 (2001).
Nicolaou et al., “Synthesis and Biological Evaluation of Vancomycin Dimers with Potent Activity against Vancomycin-Resistant Bacterwria: Target-Accelarated Combinatorial Synthesis”Chem. Eur. J.7(17):2824-2843 (2001).
Pollack, S. J. et al., “introduction of Nucelophines and Spectotroscopic Probes into Antibody Combining Sites”Science242:1038-1040 (1988).
Ramstrom and Lehn, “In Situ Generation and Screening of a Dynamic Combinatorial Carbohydrate Library against Concanavalin A”ChemBioChem1:41-48 (2000).
Sannes-Lowery et al.,Trends Anal. Chem19(8):481-491 (2000).
Shuker et al., “Discovering High-Affinity Ligands for Proteins: SAR by NMR”Science274(5292):1531 (Nov. 1996).
Stanojevic and Verdine, “Deconstruction of GCN4/GCRE into a monomeric peptide-DNA complex”Nature Structural Biology2(6):450-457 (Jun. 6, 1995).
Wetterau et al., “An MTP Inhibitor That Normalizes Atherogenic Lipprotein Levels in WHHL Rabbists”Science282:751-754 (Oct. 23, 1998).
Woodcroft et al., “N-Aralkylated derivatives of 1-aminobenzotriazole as isozyme-selective mechanism based inhibitors of guinea pig hepatic cytochrome P-450 dependent monoozygenase activity”Can J. Physiol. Pharmacol.68(9):1278-1285 (1990).
Zhang et al., “Covalent Modification and Active Site-Directed Inactivation of a low Molecular Weight Phosphotyrosyl Protein Phosphatase”Biochemistry31(6):1701-1711 (1992).

Affiliated with

Also associated with

Rating

Methods for ligand discovery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for ligand discovery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for ligand discovery will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3665709